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Summary
It has been suggested that germline stem cells main-
tain oogenesis in postnatal mouse ovaries. Here we
show that adult mouse ovaries rapidly generate hun-
dreds of oocytes, despite a small premeiotic germ cell
pool. In considering the possibility of an extragonadal
source of germ cells, we show expression of germline
markers in bone marrow (BM). Further, BM transplan-
tation restores oocyte production in wild-type mice
sterilized by chemotherapy, as well as in ataxia telan-
giectasia-mutated gene-deficient mice, which are
otherwise incapable of making oocytes. Donor-
derived oocytes are also observed in female mice fol-
lowing peripheral blood transplantation. Although the
fertilizability and developmental competency of the
BM and peripheral blood-derived oocytes remain to
be established, their morphology, enclosure within
follicles, and expression of germ-cell- and oocyte-
specific markers collectively support that these cells
are bona fide oocytes. These results identify BM as a
potential source of germ cells that could sustain oo-
cyte production in adulthood.
Introduction
A central dogma of reproductive biology has been that
females of most mammalian species lose the capacity
for oocyte production during fetal development, lead-
ing to the endowment of a finite stockpile of oocytes,
enclosed by somatic cells in structures referred to as
follicles, at or shortly after birth (Zuckerman, 1951;
Zuckerman and Baker, 1977). Only a small fraction of
the postnatal oocyte pool survives to be ovulated at
some point in reproductive life, as the fate of the vast
majority of follicles that house the oocytes is atretic de-
generation (Tilly, 2001). For example, in humans, it has
been estimated that less than 3 × 105 of the original
pool of about 1 × 106 nondegenerative oocytes present*Correspondence: jtilly@partners.orgat birth survive at puberty. This number continues to
decline throughout adulthood to the point of exhaus-
tion around age 50, driving menopause (Richardson et
al., 1987). Proportionately similar reductions in oocyte
numbers occur in mice during postnatal life (Perez et
al., 1999; Canning et al., 2003), with complete depletion
of the oocyte pool also noted long before death due to
chronological age (Gosden et al., 1983).
A recent study has, however, challenged this dogma
by showing in mice that production of oocytes (oogen-
esis) and their enclosure within somatic cells (folliculo-
genesis) persist in juvenile and adult life (Johnson et
al., 2004). Similar events occur in female flies, which
maintain oocyte production as adults via a specialized
cell population referred to as germline stem cells
(GSCs) (Deng and Lin, 2001). Although this concept has
now been extended to mammals (Johnson et al., 2004),
widespread acceptance that adult mammalian females
are indeed capable of producing new oocytes is slow
in coming (Gosden, 2004). This likely stems, at least in
part, from a lack of direct evidence for the existence of
mammalian female GSCs and their progenitors, which
would be manifest by, among other things, the ability
of such cells to rescue and sustain oocyte production
following transplantation.
Here we show that adult mouse ovaries can produce
hundreds of new oocytes within 24 hr, reinforcing the
primary conclusion from our earlier work that initially
challenged the dogma of a fixed complement of oo-
cytes at birth (Johnson et al., 2004). Moreover, based
on gene expression analyses and bone marrow trans-
plantation (BMT) experiments using chemotherapy-
sterilized recipients, a putative GSC reservoir that sup-
ports oogenesis in adult female mice appears to reside
in bone marrow (BM). Additional transplantation studies
using peripheral blood (PB) harvested from transgenic
females with germline-restricted green fluorescent pro-
tein (GFP) expression show that GFP-positive oocytes
form in chemotherapy-treated recipient females, sug-
gesting that putative germ cells in BM release progeni-
tor cells into the peripheral circulation that travel to the
ovaries for oocyte production. Although the BM- and
PB-derived cells exhibit many fundamental characteris-
tics of bona fide oocytes (e.g., morphology, presence
within follicles, expression of germ-cell- and oocyte-
specific markers), we have not yet determined whether
these oocytes can fertilize normally and develop into
viable offspring. Nonetheless, these results identify BM
and PB as potential sources of female germ cells that
could sustain oocyte production in adulthood.
Results
Oogenesis and Folliculogenesis in Adulthood
The reported existence of mammalian female GSCs
(Johnson et al., 2004) implies an inherent capacity of
the ovaries to generate new oocyte-containing follicles
in a regulated fashion. To address this, we injected
adult female mice with doxorubicin to synchronize oo-
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304cyte death (Perez et al., 1997), and ovaries were ana- f
Olyzed at multiple intervals afterwards. A rapid and
extensive loss of resting (primordial) and early-growing a
afollicles occurred within the first 24 hr after doxorubicin
treatment (Figure 1). However, spontaneous regenera- (
(tion of the immature follicle pool was observed be-
tween 24 and 36 hr posttreatment, and the number of u
afollicles stabilized thereafter such that, by 2 months
posttreatment, there were no differences between vehi- t
ncle- and doxorubicin-treated mice (Figure 1). These
data, along with results from other experiments (see w
PFigure S1 with the Supplemental Data available with
this article online), support our earlier work on the oc- o
lcurrence of oogenesis and folliculogenesis in adult fe-
male mammals (Johnson et al., 2004). 9
t
(Characterization of Adult Ovary-Derived
dGerm Cells
SAn earlier study suggested that non-follicle-enclosed
ogerm cells on the ovarian surface were logical candi-
dates for GSCs (Johnson et al., 2004). However, the
number of these cells drops precipitously as female E
omice transit through puberty (63 ± 8 versus 6 ± 3 cells
per ovary at postpartum day 30 versus day 40, respec- I
otively; mean ± SEM, n = 4 mice per group), suggesting
that these cells could not represent adult GSCs. In con- i
gsidering other strategies to potentially identify GSCs,
we focused on stage-specific embryonic antigen-1 1
s(SSEA1), a carbohydrate expressed at high levels on
primordial germ cells (PGCs) (Marani et al., 1986). Im- o
hmunohistochemical analysis of SSEA1 expression in
adult mouse ovaries revealed a cluster of SSEA1-posi- f
ative (SSEA1+) cells in the medulla (Figures S2A–S2D).
Outside of a low level of immunoreactivity occasionally g
pobserved in some scattered granulosa cells, SSEA1
was not expressed in any other area of the ovary or in D
Pany cell type of known origin, including oocytes (Fig-
ure S2A). t
nSince SSEA1 is expressed by some somatic stem cell
lineages in adults (Capela and Temple, 2002), we sub- s
ejected dispersed adult mouse ovaries to SSEA1-anti-
body-based magnetic bead sorting (Geijsen et al., a
(2004) to determine if the SSEA1+ cell pool detected
in vivo contains germ cells. Cells within the SSEA1+ oFigure 1. Spontaneous Regeneration of Oocyte-Containing Follicles in Adult Female Mice
Number of nonatretic primordial (A) or total immature (primordial, primary, small preantral [B]) follicles in ovaries of adult female mice at the
indicated times following doxorubicin (DXR) injection (5 mg/kg). Follicle numbers in vehicle (VEH)- versus DXR-treated mice at 2 months (2
mos.) postinjection are also shown. Values are the mean ± SEM from an analysis of four to five mice per treatment group.raction expressed the POU domain transcription factor
ct4, which plays a key role in stem cell pluripotency
nd early germ cell development (Schöler et al., 1989),
s well as the germline markers mouse Vasa homolog
Mvh) (Fujiwara et al., 1994; Noce et al., 2001), Dazl
Cooke et al., 1996) and Stella (Saitou et al., 2002) (Fig-
re S2E). As expected, all four germline markers were
lso expressed in the residual cell fraction, which con-
ains oocytes (Figure S2E). However, SSEA1+ cells did
ot express synaptonemal complex protein 3 (Scp3),
hich marks meiotic entry in germ cells (Cohen and
ollard, 2001). Moreover, we failed to detect expression
f several oocyte markers, including histone deacety-
ase 6 (Hdac6; Figure S3), growth differentiation factor
(Gdf9; McGrath et al., 1995), and zona pellucida pro-
ein 3 (Zp3; Philpott et al., 1987), in the SSEA1+ cells
Figure S2E). These data, and the finding that oocytes
o not express SSEA1 (Figure S2A), indicate that the
SEA1+ cell fraction contains germ cells that are not
ocytes.
xpression of Germline Markers in BM
f Adult Mice
f GSCs were represented by SSEA1+ germ cells in the
vary, the relatively small size of this cell pool would be
ncongruous with the ability of adult mouse ovaries to
enerate hundreds of new oocytes in only 24 hr (Figure
, Figure S1). Accordingly, we next considered the pos-
ibility that a GSC reservoir exists somewhere outside
f the ovaries. During embryogenesis, PGCs and
ematopoietic stem cells (HSCs) are known to originate
rom the same region—the proximal epiblast (Lawson
nd Hage, 1994). Early HSCs then colonize the aorta-
onad-mesonephric region of the developing embryo
rior to migration into the fetal liver (Medvinsky and
zierzak, 1996), at roughly the equivalent time that
GCs enter the same region of the embryo to colonize
he fetal gonads (Molyneaux and Wylie, 2004). In post-
atal life, the hematopoietic system is maintained by
tem cells that home to and reside in the BM (Morrison
t al., 1995). This information, along with the reported
bility of PGCs to generate primitive HSCs in vitro
Rich, 1995) and the increasing number of studies dem-
nstrating the multilineage potential of BM-derived
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305cells (Herzog et al., 2003; Grove et al., 2004; Heike and
Nakahata, 2004), prompted us to examine if germ cells
could be identified in adult female BM.
Initial experiments demonstrated expression of Oct4,
which in adult mice is reportedly restricted to germ
cells (Schöler et al., 1989; Yoshimizu et al., 1999), as
well as Mvh, Dazl, Stella, and a fifth germline marker
gene termed Fragilis (Saitou et al., 2002), in BM isolated
from adult female mice (Figures 2A–2D). In addition, ex-
pression of the female-germ-cell-specific homeobox
gene Nobox (Suzumori et al., 2002), which is critical for
directing expression of Oct4 and Gdf9 in primordial oo-
cytes as well as for folliculogenesis (Rajkovic et al.,
2004), was detected in BM of adult females (Figure 2A).
Independent confirmation of our findings that multiple
germline markers are expressed in mouse and human
BM was provided by analysis of public microarray data-
bases. For example, expression of Mvh, Dazl, Stella,
and Fragilis has been identified in mouse BM (http://
genome.ucsc.edu; Benson et al., 2004; Su et al., 2004),
and STELLA expression has been identified in human
BM (http://genome.ucsc.edu; GenBank Accession Num-
ber CV414052 from Dias Neto et al. [2000]). Consistent
with results from this latter study, we also detected
germline markers in BM obtained from human female
donors between the ages of 24 and 36 (Figure S4).
Given the large number of studies documenting the
germ-cell-restricted nature of Vasa expression through-
out the animal kingdom (Noce et al., 2001), we selected
Mvh to quantitatively assess potential changes in germ-
line marker expression in BM during the female reprod-
uctive cycle. Using real-time PCR, marked estrous-
cycle-related changes in Mvh expression in BM of adult
female mice were uncovered, with a 9.52-fold differ-
ence noted between estrus (nadir) and metestrus
(peak) (Figure 2E). A parallel evaluation of ovarian germ
cell dynamics revealed a positive correlation between
the cycle-related changes in BM Mvh expression and
oocyte numbers, with ovaries at metestrus containing
over 800 more primordial follicles than ovaries at estrus
(Figure 2F). We then examined the effect of ovariec-
tomy, without or with subsequent ovarian steroid sup-
plementation, on BM Mvh levels. Removal of the
ovaries caused a near-complete elimination of Mvh ex-
pression in BM, and replacement of estrogen, proges-
terone, or the two steroids together did not alter BM
Mvh levels in ovariectomized females (Figure 2G). In
parallel studies, we observed that Mvh levels in BM of
adult females at metestrus were 1.6% of those de-
tected in adult ovaries (Table S1), which contain thou-
sands of Mvh-expressing oocytes (Fujiwara et al., 1994;
Figure 2D). Interestingly, Mvh expression was also de-
tected in BM of adult male mice, with a level of expres-
sion slightly less than 20% of that detected in BM of
adult females at metestrus (Table S1).
We next sorted BM samples based on cell surface
stem cell markers and quantitatively analyzed the resul-
tant cell fractions for Mvh levels. After removal of dif-
ferentiated cells committed to hematolymphoid lin-
eages by negative selection (Spangrude et al., 1988),
Mvh expression was retained in the lineage-depleted
(lin−) cell fraction (Figure 3A). Subsequent separation of
lin− cells based on cell surface expression of Sca-1 (Van
de Rijn et al., 1989) or c-Kit (Okada et al., 1991) showedthat the majority (82.9%) of the Mvh-expressing lin−
cells were negative for expression of Sca-1 but positive
for c-Kit (Sca-1−/c-Kit+) (Figure 3A). Moreover, expres-
sion of Dazl, Stella, and Fragilis cosegregated with Mvh
in the lin−/Sca-1−/c-Kit+ cell fraction (Figure S5). In par-
allel experiments, in vitro culture of adult female BM-
derived cells under conditions that permit the pro-
gressive enrichment of stem cells from BM (Meirelles
Lda and Nardi, 2003) demonstrated that all of the germ-
line markers present in freshly isolated BM were ex-
pressed by the adherent cell fraction and remained so
following multiple serial passages over a 6 week period
(Figure 3B).
BMT Rescues Oocyte Production
in Sterile Adult Females
To assess if putative BM-derived germ cells could gen-
erate oocytes, BM was isolated from adult wild-type
female mice and transplanted into recipient adult fe-
males sterilized by pretreatment with cyclophospha-
mide and busulfan to destroy the existing pre- and
postmeiotic germ cell pools (Shiromizu et al., 1984;
Johnson et al., 2004). Ovaries were then collected, and
the presence of oocytes was determined by their mor-
phological appearance, their enclosure within histologi-
cally normal follicles, and, in some experiments, ex-
pression of germ-cell- and oocyte-specific markers.
Two months after treatment, very few, if any, immature
oocytes or follicles were detected in the ovaries of
those females given cyclophosphamide and busulfan
alone (Figures 4A–4C, Figures S6A–S6B). However,
ovaries of mice receiving BMT 1 or 7 days after chemo-
therapy possessed several hundred oocyte-containing
follicles at all stages of development, including the rest-
ing primordial stage (Figures 4A and 4D, Figure S6C).
Histological evaluations showed that the chemotherapy
regimen essentially destroyed the ovaries—which, after
treatment, were composed of little more than stromal
and interstitial cells with an occasional cystic follicle or
old corpus luteum (Figure 4C, Figure S6B). By compari-
son, ovaries of mice receiving BMT—even when the
transplants were given a week after inflicting the dam-
age to the tissue—possessed a complete spectrum of
immature and mature oocyte-containing follicles as
well as corpora lutea indicative of a resumption of nor-
mal ovulatory cycles (Figure 4D, Figure S6C). Further-
more, oocytes and follicles were found in ovaries of
chemotherapy-sterilized females more than 11 months
after the initial transplantation (Figures 4E and 4F), indi-
cating that the putative BM-derived germ cells are ca-
pable of sustaining long-term oocyte production.
To further establish that putative germ cells present
in BM can generate oocytes, BMT was next performed
in adult female mice with a targeted disruption in the
ataxia telangiectasia-mutated (Atm) gene. This line of
mutant mice was selected based on past studies show-
ing that Atm-deficient mice lack the ability to produce
mature germ cells due to the critical role that this ki-
nase plays in early meiotic progression (Barlow et al.,
1998). In females, neonatal Atm mutants are devoid of
oocytes and remain so throughout postnatal life (Di
Giacomo et al., 2005). However, consistent with the fact
that premeiotic germ cell development occurs normally
Cell
306Figure 2. Ovarian-Regulated Expression of Germline Markers in BM
(A) Germline marker expression in BM of adult wild-type female mice. As a positive control for expression of germline markers, adult mouse
ovary RNA was analyzed in parallel. Oct4 mRNA was low in abundance and not consistently detected in all BM samples. L7, “housekeeping”
gene. Mock, mock reverse-transcribed BM RNA samples.
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307tinued production of oocytes and follicles in postnatalthe possibility of a nonspecific “restorative” effect of
(B and C) Analysis of MVH immunoreactivity (red, with nuclei highlighted by propidium iodide in blue) in BM of adult wild-type female mice.
(D) Mouse ovary analyzed in parallel as a positive control for the immunostaining shown in (B) and (C), demonstrating a restricted expression
of MVH (red) to germ cells (oocytes).
(E) Real-time PCR analysis of Mvh levels in BM or PB of adult female mice during the indicated stages of the estrous cycle. The data shown
represent the combined results from an analysis of three to four mice per group, with mean levels at estrus set as the reference point for
comparisons to other stages of the cycle following normalization of the data against β-actin for sample loading. For mice in estrus, Mvh
expression in bone marrow was detected during linear amplification in only one of the three samples analyzed. See Table S1 for additional re-
sults.
(F) Number of nonatretic primordial oocyte-containing follicles in adult female mice at the indicated stages of the estrous cycle (mean ± SEM,
n = 4 mice per group).
(G) Quantitative PCR analysis of Mvh levels in BM of adult female mice 2 weeks following ovariectomy (OVEX) without (no treatment, No Tx)
or with subsequent supplementation of estrogen (E2, 100 ng/mouse) and/or progesterone (P4, 2 mg/mouse) for the final 24 hr before BM
collection. The OVEX data shown represent the combined results from an analysis of three mice per group, with mean BM Mvh levels in
ovary-intact female mice at estrus set as the reference point for comparisons (BM Mvh levels in ovary-intact metestrus stage female mice
are also provided for reference) following normalization of the data against β-actin to control for sample loading.in the absence of Atm, analysis of adult Atm-deficient
ovaries revealed expression of Oct4, Mvh, Dazl, and
Stella (Figure S7). Although mutant females are incapa-
ble of generating oocytes from early germ cells, Atm
null female mice were nonetheless conditioned with
cyclophosphamide and busulfan to eliminate the possi-
bility of host germ cell contribution to oocyte produc-
tion following BMT. In contrast to the expected and
complete absence of oocytes in nontransplanted Atm
mutants (Figure 5B; no oocytes or follicles were ob-
served in ovaries of ten animals total), oocyte-contain-
ing follicles were found in the transplanted mutant fe-
males and remained detectable more than 11 months
after the initial BMT (Figures 5C–5G, Table S2).
Generation of Oocytes by Peripheral
Blood Cell Transplantation
If BM houses female GSCs, then the progeny from
these putative germ cells would likely utilize the PB
supply for travel to the ovaries. We therefore next deter-
mined if peripheral blood cell transplantation (PBCT)
could contribute to oocyte production in transplanted
female recipients. In the first of three experiments, we
used transgenic female mice with GFP expression
driven by an 18 kb fragment of the Oct4 promoter in
which the proximal enhancer region has been inacti-
vated (GOF18-PE or TgOG2) (Yeom et al., 1996; Yo-
shimizu et al., 1999; Szabo et al., 2002) as donors for
PBCT. Past studies have reported that endogenous
Oct4 expression in adult animals is restricted to germ
cells (Schöler et al., 1989; Yoshimizu et al., 1999), and
the introduction of deletions in the proximal enhancer
of the Oct4 promoter (PE) leads to exclusive expres-
sion of the transgene in the germline even during
embryogenesis (Yeom et al., 1996). As controls, GFP
expression was detected only in primordial and grow-
ing oocytes of transgenic females (Figures 6A and 6B),
and the GFP signal was absent in oocytes of wild-type
females prior to PBCT (Figure 6C). However, primordial
follicles with highly GFP-positive (GFP+) oocytes were
detected in the ovaries of chemoablated adult wild-
type female mice within 28–30 hr of PBCT (Figures 6D–
6F; see also Figure 7).
Similar findings were obtained when the experiments
were repeated using chemoablated Atm null female
mice as recipients (Figures 6G and 6H), thus excludingPBCT on endogenous oocyte production in the host
females. Moreover, transplantation of PB-derived mono-
nuclear cells harvested from adult male TgOG2 mice,
which also exhibit abundant expression of the trans-
gene in germ cells (Figures S8A–S8C), did not result
in the production of GFP+ oocytes in female recipients
(Figures S8D–S8F), ruling out the possibility that the oo-
cytes observed following transplantation of female PB
developed as a result of cell fusion. Further, the GFP+
cells contained within follicles of hosts following trans-
plantation of PB collected from adult female TgOG2
mice expressed MVH (Figures 7A–7F), HDAC6 (Figures
7G–7L), NOBOX (Figures 7M–7O), and GDF9 (Figures
7P–7R), supporting their status as germ cells (MVH,
Noce et al. [2001]) and oocytes (HDAC6, Figure S3;
NOBOX, Suzumori et al. [2002]; GDF9, McGrath et al.
[1995]). In a final experiment, doxorubicin-treated mice
(Figure 1) were used as recipients for transplantation of
PB collected from adult transgenic female mice with
ubiquitous GFP expression (Hadjantonakis et al., 1998).
Despite the fact that different conditioning and different
transgenic donor cells were used, similar results were
obtained in that primordial follicles containing GFP+ oo-
cytes were observed shortly after PBCT (Figure S9).
Irrespective of the model, the number of follicles con-
taining GFP+ oocytes in the recipient ovaries at 28–30
hr posttransplantation was variable (mean of 13 ± 3,
ranging between 3 and 33 per ovary; n = 9). In light of
the striking estrous-cycle-related changes in BM Mvh
expression discussed earlier (Figure 2E), one aspect of
the PBCT procedure that may impact on the number
of donor-derived oocytes generated is the stage of the
donor female’s reproductive cycle during which blood
is harvested for transplantation. Accordingly, PB was
collected from adult female mice during estrus, metes-
trus, diestrus, and proestrus and analyzed by real-time
PCR for Mvh expression. These experiments demon-
strated that Mvh levels in PB, like those in BM, varied
during the estrous cycle (Figure 2E; see also Figure
S10). Lastly, like that observed for human female BM,
we also detected expression of germline markers in PB
of human females between the ages of 23 and 33 (Fig-
ure S4).
Discussion
We recently provided evidence demonstrating the con-
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cFigure 3. Properties of Putative Germ Cells in Adult Female BM
(A) Quantitative analysis of Mvh levels in crude BM and lineage- e
depleted (lin−) BM samples without or with further fractionation by i
FACS based on cell surface expression of Sca-1 or c-Kit. All re-
dmaining lin− cells not represented in the Sca-1−/c-Kit+ cell fraction
oof the were pooled and analyzed together (Other). The data shown
trepresent the combined results from an analysis of three adult fe-
male mice, with mean Mvh levels in the crude BM sample set as a
the reference point for comparisons following normalization of the p
data against β-actin for sample loading. See Figure S5 for addi- a
tional data. o
(B) Germline marker expression in adherent BM-derived cells fol-
rlowing a total of three serial passages (P3) over a 6 week period
ein vitro. BM, freshly isolated bone marrow. β-actin, housekeeping
tgene. Mock, mock reverse-transcribed BM RNA samples.
e
p
mouse ovaries, thus challenging a long-held belief that a
female mammals are born with a finite and nonrenew-
ing oocyte reserve (Johnson et al., 2004). The present g
studies confirm and extend this earlier conclusion and f
raise the possibility that GSCs in adult female mammals c
may actually reside in BM. In this regard, the fraction- o
ation strategies provide initial insight into some of the l
basic characteristics of these putative BM-derived w
germ cells. First, Mvh-expressing cells were retained w
following negative selection against cell surface mark- m
ers characteristic of differentiated cells of the hemato- Y
lymphoid lineage (Spangrude et al., 1988). More impor- o
tantly, however, further sorting of the Mvh-expressing s
lin− cells based on cell surface expression of stem cell t
tmarkers revealed that these putative BM-derived germells express c-Kit but not Sca-1, thus classifying them
s entities distinct from HSCs, which express both
arkers (Van de Rijn et al., 1989; Okada et al., 1991,
992; Wognum et al., 2003). The finding that Mvh-
xpressing cells were retrieved from lin− cells by posi-
ive selection for c-Kit is fully consistent with past
tudies documenting the critical role of c-Kit in early
erm cell development (Sette et al., 2000). Of note,
ther germline-associated genes were also expressed
n the lin−/Sca-1−/c-Kit+ cell fraction, suggesting that a
ommon pool of cells in BM expresses this gene pro-
ile. This conclusion was bolstered by in vitro culture of
dult female BM-derived cells, which demonstrated
hat our panel of germline markers cosegregated with
he adherent cell fraction and remained so following se-
ial passage.
Although the expression of germline markers in BM
nd PB was initially a surprise, several lines of evidence
ndicate that these results support the existence of ex-
ragonadal germ cells in adult females. First and fore-
ost, mononuclear cells derived from either source
ere capable of generating oocytes in sterilized female
ecipients (see also discussions below). In addition, we
etected multiple germline markers, not just a single
ermline-associated gene, in BM and PB, and at least
ne of these genes (Mvh) has been consistently iden-
ified as a specific germ cell marker (Noce et al., 2001).
urther, the levels of Mvh expression in BM and PB of
dult female mice were dramatically influenced by the
strous cycle. This finding is even more striking when
onsidered with the estrous-cycle-related shifts in pri-
ordial follicle numbers identified in the same females.
n a study conducted in mice more than 80 years ago,
llen (1923) similarly concluded that 400–500 new oo-
ytes are produced in adult females during each
strous cycle, with the highest and lowest numbers of
mmature oocytes also observed during metestrus/
iestrus and estrus, respectively. The results from the
variectomy experiments lend further support to the exis-
ence of a novel communication loop between the ovaries
nd BM that may regulate the extent of de novo oocyte
roduction each cycle. This may serve to counterbal-
nce the constantly high level of oocyte loss normally
bserved in adult animals and thus allow the ovaries to
emain functional for more than a few weeks (Johnson
t al., 2004). Interestingly, the ovarian-derived signal(s)
hat regulates the level of BM Mvh expression is neither
strogen nor progesterone—arguably the two most
rominent hormones secreted by the female gonads in
n estrous-cycle-stage-specific manner.
In addition to BMT, we showed that PB is capable of
enerating oocytes following transplantation into adult
emale recipients. That these oocytes are derived from
ells in the donor blood is supported by a number of
bservations. First, the Oct4-GFP (TgOG2) transgenic
ine used to provide “marked” donor cells has been
ell-characterized in terms of transgene expression,
hich by virtue of the PE mutation in the Oct4 pro-
oter is restricted to the germline (Yeom et al., 1996;
oshimizu et al., 1999). Thus, the appearance of GFP+
ocytes in recipient ovaries following PBCT is fully con-
istent with the specificity of transgene expression in
he donor animals. Second, GFP+ oocytes were de-
ected following PBCT in wild-type female recipients
Adult Oocyte Production by Extragonadal Germ Cells
309Figure 4. BMT Rescues Oocyte Production
in Chemotherapy-Sterilized Female Mice
(A) Number of nonatretic immature follicles
in wild-type female mice 60 days after treat-
ment with cyclophosphamide and busulfan
on day 42 postpartum without or with BMT
1 or 7 days (d) later. Values are the mean ±
SEM from analysis of five mice per group,
with four of the five chemoablated mice not
receiving BMT completely lacking immature
oocytes.
(B–D) Representative ovarian histology in
adult female mice treated with vehicle and
no BMT ([B], control), combination chemo-
therapy without BMT ([C]; CF, cystic follicle),
or combination chemotherapy with BMT per-
formed 7 days later (D), as described in (A).
Asterisks denote corpora lutea in (B) and (D),
whereas the arrowhead in (D) points to a
large healthy oocyte contained within a ma-
ture antral follicle. See Figure S6 for addi-
tional examples and results.
(E and F) Ovarian histology of adult wild-type
female mice 11.5 months after combination
chemotherapy followed by BMT on day 42
postpartum. Follicles at various stages of
maturational development are highlighted
(insets).that had received prior conditioning with a combination
chemotherapy regimen known to be extremely cyto-
toxic to both pre- and postmeiotic germ cells (Shiro-
mizu et al., 1984; Johnson et al., 2004). Since cell fusion
is dependent on the presence of differentiated cells of
a given lineage—in this case, germ cells—in the host
for donor cells to combine with (Herzog et al., 2003), it
is unlikely that cell fusion could explain oocyte produc-
tion in the chemotherapy-conditioned females follow-
ing PBCT (or BMT). Third, similar findings were ob-
tained when chemoablated Atm-deficient females were
used as recipients for PBCT. If one considers that these
mutant mice are genetically incapable of producing oo-
cytes during postnatal life (Barlow et al., 1998; Di Giac-
omo et al., 2005), the possibility that the GFP+ oocytes
observed in recipient ovaries following PBCT were gen-
erated as a result of some nonspecific protective or re-
storative effect of PB on host-germ-cell-supported oo-
genesis can be excluded. Fourth, PBCT using male
TgOG2 mice as donors, which also express high levels
of GFP in the germline, was completely ineffective in
producing GFP+ oocytes in recipient females, further
eliminating the possibility that cell fusion is involved.It is important to emphasize that we do not yet know
if the oocytes produced as a result of BMT or PBCT
are competent for fertilization, embryonic development,
and the generation of viable offspring. Until experi-
ments have been completed to rigorously test this, we
feel it is reasonable to refer to the BM- and PB-derived
cells that generate what appear to be oocytes as puta-
tive germ cells. However, it is equally important to em-
phasize that the vast majority of oocyte-containing folli-
cles produced by the ovaries under normal conditions
die off and are not used directly for procreation (Tilly,
2001). Nonetheless, these follicles are still functional up
until the point of their demise in that they play a critical
role in the propagation of each ovarian cycle. Keeping
these points in mind, the donor-derived oocytes formed
following BMT or PBCT meet several other well-estab-
lished criteria that support their status as bona fide oo-
cytes.
First, from a histological perspective, follicle assem-
bly is one of the most widely accepted and time-tested
hallmarks for deeming when a female germ cell is an
oocyte (Peters, 1969; Hirshfield, 1991). In fact, both fol-
liculogenesis and the subsequent maturational devel-
Cell
310Figure 5. Wild-Type BM Generates Oocytes
in Atm Mutant Females
(A and B) Histology of adult wild-type (A) and
Atm−/− (B) mouse ovaries. Scale bars are
provided to highlight large difference in
ovary size between the two genotypes.
(C and D) Oocyte-containing follicles in ova-
ries of chemoablated Atm−/− female mice at
11.5 months following transplantation with
wild-type BM at 6 weeks of age. Follicles in
hatched black boxes are highlighted (insets).
(E–G) Oocyte-containing follicle in an Atm
mutant mouse 2.5 months after BMT, as
viewed by MVH immunofluorescence (green;
nuclear DNA highlighted by TO-PRO-3 in
blue).opment of follicles, once formed, require active partici- g
tpation by functional oocytes (Erickson and Shimasaki,
2000; Matzuk et al., 2002). Mutant mice lacking Gdf9 i
t(Dong et al., 1996) and Nobox (Rajkovic et al., 2004)
are particularly illustrative of the critical role played by e
ioocytes and their specific gene repertoire in follicular
dynamics. Accordingly, and in keeping with the findings t
athat the donor-derived oocytes were enclosed within
histologically normal follicles, these cells were shown i
rto express markers of not just germ cells (MVH) or pri-
mordial oocytes (HDAC6) but of functional oocytes S
t(NOBOX, GDF9) that have fulfilled their intrinsic contri-
bution to follicle formation, survival, and growth. t
dAdditional evidence that the oocytes produced fol-
lowing transplantation are bona fide functional oocytes a
ois provided by the striking differences in the overall his-
tological architecture of the ovaries in the chemoablated b
ofemales without or with subsequent BMT. Specifically,
ovaries of female mice receiving BMT after combination e
chemotherapy were histologically indistinguishable from
those of untreated controls in that the ovaries of both wroups contained a full spectrum of immature and ma-
ure oocyte-containing follicles as well as corpora lutea
ndicative of normal ovulatory cycles. It is unlikely that
his outcome simply reflects a nonspecific “protective”
ffect of BM on the gonads since chemotherapy-
nduced ovarian failure was reversed by BMT irrespec-
ive of whether the transplant was performed shortly
fter (1 day) or well after (7 days) the damage had been
nflicted. Furthermore, BMT was ineffective at rescuing
adiation-induced ovarian failure (Figures S6D and
6E), despite past studies showing that depletion of
he oocyte pool in adult female mice by ionizing radia-
ion can be prevented using other approaches aimed
irectly at protecting the resident germ cells (Morita et
l., 2000). Therefore, BMT not only rescues production
f what appear to be bona fide oocytes and follicles
ut also, as a consequence, the functional properties
f an organ that without BMT would have otherwise
xhibited permanent failure.
Interestingly, we also detected expression of Mvh, as
ell as Dazl and Stella (data not shown), in BM of adult
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311Figure 6. Female PB Generates Oocytes fol-
lowing Transplantation
(A and B) Follicles containing GFP-positive
(brown) oocytes in ovaries of adult Oct4-GFP
transgenic mice ([A], multiple primordial oo-
cytes are highlighted). Scale bar, 10 m.
(C) Oocytes (arrowhead or boxed) in a wild-
type ovary prior to PBCT using Oct4-GFP
(TgOG2) females as donors, showing a lack
of GFP signal (inset, primordial oocyte).
(D–F) Primordial follicles containing GFP-
positive oocytes in ovaries of wild-type fe-
male mice 28–30 hr after PBCT, using adult
TgOG2 transgenic females as PB cell donors
(see also Figure 7). Scale bars, 10 m.
(G and H) GFP-positive primordial oocytes in
ovaries of Atm-deficient females 30 hr after
PBCT using adult TgOG2 transgenic females
as donors. Scale bars, 10 m.male mice. Although the levels of BM Mvh expression in
males were less than 20% of those in metestrus-stage
females analyzed in parallel, such results were none-
theless unexpected, since it is known that male GSCs
reside in the testes (Brinster, 2002). In the only past
study we could find that has directly examined the
prospects of extragonadal support of adult gamete
production, it was reported that spermatogenesis in
male rats sterilized by radiation could not be rescued
by BMT. Further, there was no spontaneous resumption
of spermatogenesis in male rats when the radiation was
directed only at the testes, thus sparing any potential
extragonadal germ cells from radiation-induced death
(Green and Bernstein, 1970). However, we similarly ob-
served that oocyte production and ovarian function in
adult female mice exposed to radiation could not be
rescued by BMT (Figures S6D and S6E), collectively
suggesting that radiation-induced damage to the go-
nads is so broad and severe that the ability of germ
cell progenitors to engraft in the tissue and function
following irradiation is disrupted to the point of failure.
Accordingly, it may prove informative to repeat the BMT
studies in males using a model for inducing spermato-
genic failure, such as busulfan exposure, which is ame-nable to rescue by male GSC transplantation (Brinster
et al., 2003).
Experimental Procedures
Animals
Wild-type C57BL/6 female mice were obtained from Charles River
Laboratories (Wilmington, Massachusetts). Mutant mice lacking
Atm (129S6/SvEvTac-Atmtm1-Awb) and transgenic mice with ubiqui-
tous GFP expression (STOCK TgN[GFPU]5Nagy) were obtained
from Jackson Laboratories (Bar Harbor, Maine). Oct4-GFP trans-
genic mice (TgOG2) were obtained from J.R. Mann through K.J.
MacLaughlin (University of Pennsylvania, Kennett Square, Pennsyl-
vania). Estrous cyclicity was determined by daily monitoring of va-
ginal cytology (Cooper et al., 1993). The institutional animal care
and use committee of Massachusetts General Hospital approved
all animal procedures.
Human Subjects
Cryopreserved BM or PB samples from female donors between 24
and 36 (BM) or 23 and 33 (PB) years of age were utilized for these
studies, following approval of the protocol (#2004-P-001665/1) by
the human research committee of Massachusetts General Hospital.
Ovarian Histology and Oocyte Counts
After fixation, ovaries were sectioned and stained for light micro-
scopic evaluation. In some experiments, serial ovarian sections
Cell
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Figure 7. PBCT-Derived Ovarian Follicular
Cells Express Germline and Oocyte Markers
Dual immunofluorescence analysis showing
coexpression of GFP (green) and MVH (red)
(A–F), GFP (green) and HDAC6 (red) (G–L),
GFP (green) and NOBOX (red, note the
nuclear localization) (M–O), or GFP (green)
and GDF9 (red) (P–R) in oocytes of immature
follicles within ovaries of recipient female
mice 28–30 hr after transplantation with PB
harvested from adult Oct4-GFP (TgOG2)
transgenic females (see Figure 6 for con-
trols). Asterisks in (P) and (Q) denote auto-
fluorescent red blood cells. All cell nuclei are
highlighted by TO-PRO-3 iodide staining
(blue) in the merged panels. Scale bars,
10 m.
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313were analyzed by histomorphometry to determine the number of
nonatretic or atretic oocyte-containing follicles per ovary (Tilly,
2003; Johnson et al., 2004).
Immunohistochemistry
Ovaries, testes, and bones (femurs) were fixed in 4% neutral-buf-
fered paraformaldehyde, and bones were then decalcified for 72 hr
in formic acid-EDTA. The tissues were sectioned for immunohisto-
chemical analysis using antibodies specific for SSEA1 (MAB4301;
Chemicon, Temecula, California), MVH (generously provided by T.
Noce; Fujiwara et al., 1994), HDAC6 (2162; Cell Signaling Technol-
ogy, Beverly, Massachusetts), NOBOX (generously provided by A.
Rajkovic; Suzumori et al., 2002), GDF-9 (AF739; R&D Systems, Min-
neapolis, Minnesota) or GFP (sc-9996; Santa Cruz Biotechnology,
Santa Cruz, California) after high-temperature antigen unmasking,
as recommended by each supplier. For the studies involving trans-
genic mice with ubiquitous GFP expression, antigen detection was
visualized after tyramide amplification (PerkinElmer, Boston, Mas-
sachusetts). For immunoflourescence-based antigen detection,
sections were mounted with propidium iodide (Vectashield; Vector
Labs, Burlingame, California) or TO-PRO-3 iodide (Molecular
Probes, Eugene, Oregon), and images were captured using a Zeiss
LSM 5 Pascal Confocal Microscope.
Isolation of SSEA1+ Cells
Ovaries from female mice between 6 and 9 weeks of age were
cleaned of adherent tissue, minced, and incubated in Dulbecco’s
modified Eagle’s Medium (DMEM) containing 1 mg/ml collagenase
for 45 min at 37°C. The digested tissue was then spun through a
40 m cell strainer at 1000 × g for 10 min, after which the superna-
tant was removed and the pelleted cells were resuspended in
DMEM. Anti-mouse IgM beads (Dynabeads M-450; Dynal Biotech)
precoated with mouse monoclonal SSEA1 antibody (MAB4301;
Chemicon) were then added to the cell suspension, and separation
of SSEA1+ cells was performed according to the manufacturer’s
protocol.
FACS and Serial Passage Fractionation of BM
Bone marrow was isolated from adult female mice and sorted using
a BD Biosciences FACScalibur cytometer based on cell surface
expression of Sca-1 (Van de Rijn et al., 1989) and/or c-Kit (Okada
et al., 1991, 1992) following an initial fractionation step to obtain
lineage-depleted cells (Spangrude et al., 1988; Spangrude and
Scollay, 1990). For enrichment of BM-derived stem cells in vitro
(Meirelles Lda and Nardi, 2003), BM isolated from adult female mice
was plated on plastic in DMEM (Fisher Scientific, Pittsburgh, Penn-
sylvania) with 10% fetal bovine serum (Hyclone, Logan, Utah), peni-
cillin, streptomycin, L-glutamine, and amphotericin-B. Forty-eight
hours after the initial plating, the supernatants containing nonad-
herent cells were removed and replaced with fresh culture medium,
and the cultures were then maintained and passed once conflu-
ence was reached for a total of three times over the span of 6
weeks.
Reverse Transcription-PCR Analysis
Total RNA was extracted from each sample, and 1 g was reverse
transcribed (Superscript II RT; Invitrogen, Carlsbad, California)
using oligo-dT primers. Amplification via 28–45 cycles of PCR was
then performed using Taq polymerase and Buffer-D (Epicentre,
Madison, WI) with primer sets specific for each gene (Table S3).
For each sample, RNA encoded by the ribosomal gene L7 (mouse
studies), β-actin (mouse studies), or the glyceraldehyde-3-phos-
phate dehydrogenase gene (GAPDH; human studies) was amplified
and used as a loading control. All PCR products were isolated,
subcloned, and sequenced for confirmation. For quantitative analy-
sis of Mvh levels, PCR was performed using a Cepheid Smart Cy-
cler II and primers specific for amplification of Mvh (FAM-labeled
LUX Fluorogenic Custom Primers, Invitrogen; forward 5#–3#: CAC
CTCAGAGGGTTTTCCAAGCGAGGG; reverse 5#–3#: CCTCTTCT
GAACGGGCCTGA) and β-actin (LUXPrimer Sets for Housekeeping
Genes 101M-01; Invitrogen). Expression ratios were calculated
using the method of Pfaffl (2001), with Mvh levels in bone marrow
at estrus set as the reference point (1.0) for comparisons.Transplantation Studies
Bone marrow was harvested from wild-type C57BL/6 female mice
between 6 and 10 weeks of age, and 2–5 × 107 cells were injected
intravenously via the tail vein into recipients using standard pro-
cedures. To prepare recipients, wild-type or Atm null female mice
received 0.5 mg anti-CD4 antibody (GK1.5; Dialynas et al., 1984)
and 1 mg anti-CD8 antibody (2.43; Sarmiento et al., 1980) 1 week
prior to injection of 120 mg/kg cyclophosphamide (Cytoxan; Bris-
tol-Meyers Squibb, New York, New York) and 12 mg/kg busulfan
(Sigma) at 6 weeks of age. BMT was performed 1 or 7 days later,
and ovaries were collected at indicated times following BMT. In
other experiments, wild-type female mice were subjected to whole-
body irradiation (0.5 Gy total, at a rate of 89 rads/min from a 137ce-
sium source) followed by mock transplantation or BMT 1 day later,
and ovaries were collected 2 months afterward for analysis.
For PBCT, blood was harvested from adult transgenic female
mice with Oct4-specific or ubiquitous expression of GFP (see Ani-
mals above), or from adult male Oct4-GFP transgenic mice, and
layered on Ficoll-Paque Plus (Amersham Biosciences/GE Health-
care, Piscataway, New Jersey). The samples were centrifuged at
800 × g for 15 min at 4°C, and mononuclear cells were collected
from the Ficoll-buffer interface. The cells were washed and resus-
pended in PBS at a final concentration of 2–4 × 107 cells/ml. In
some experiments, recipient adult wild-type or Atm null female
mice were conditioned with chemotherapy as described above for
BMT, followed by PBCT (0.5 ml of cells per mouse, via the tail vein)
24 hr later. In other experiments, recipient adult wild-type female
mice were injected with doxorubicin (5 mg/kg) 25 hr prior to PBCT.
In all cases, ovaries were collected 28–30 hr after PBCT and ana-
lyzed for GFP expression by immunohistochemistry. For experi-
ments involving PBCT using males as donors, recipient ovaries
were fixed, serially sectioned, and screened in their entirety for
GFP-expressing oocytes.
Supplemental Data
Supplemental Data include supplemental text, ten figures, and
three tables and can be found with this article online at http://
www.cell.com/cgi/content/full/122/2/303/DC1/.
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